. In addition, and in contrast to S. cerevisiae, healing of broken DNA ends also occurs efficiently by nonhomologous end-joining (13) . However, studies on the repair of DSBs in mammalian chromosomal DNA have been limited, due to the lack of expression systems for rare-cutting, site-specific endonucleases.
ABSTRACT
The repair ofDNA double-strand breaks (DSBs) is important for the maintenance of genomic integrity in all organisms. In Saccharomyces cerevisiae, results from a number of studies have demonstrated that DSBs are primarily repaired by homologous recombination. Two distinct pathways have been implicated in the repair-DSB repair (1) and singlestrand annealing (2) (3) (4) (5) . DSB repair is conservative, whereas single-strand annealing proceeds by a nonconservative mechanism in which some genetic information is lost. Experiments in mammalian cells with transfected DNA have shown that both of these homologous recombination pathways are operational (6) (7) (8) (9) (10) (11) (12) . In addition, and in contrast to S. cerevisiae, healing of broken DNA ends also occurs efficiently by nonhomologous end-joining (13) . However, studies on the repair of DSBs in mammalian chromosomal DNA have been limited, due to the lack of expression systems for rare-cutting, site-specific endonucleases.
I-Sce I, which was discovered during analysis of the w genetic system in S. cerevisiae, is one such endonuclease (reviewed in ref. 14) . At the molecular level, c+ strains have an intron in the mitochondrial large rRNA gene. The intron efficiently moves (homes) to the intronless rRNA gene of wstrains, creating a new a+ allele (15, 16) . Further analysis demonstrated that an endonuclease (I-Sce I) is encoded within the c+ intron and that a DSB appears transiently at the site of intron insertion in w mitochondrial DNA (17) . The DSB is repaired from the homologous w+ DNA by a gene conversion mechanism, details of which are compatible with the DSB repair model. Subsequent to the analysis of the co system, many other examples of intron homing and homing endonucleases have been identified in a variety of organisms (14, 18) , some of which are encoded in protein introns (19) .
The length of the recognition site for I-Sce I and related endonucleases is longer than that of bacterial restriction enzymes. Mutagenesis of the site of intron insertion has shown that I-Sce I recognizes an 18-bp nonpalindromic sequence (20) . The enzyme has been purified (21) , and its DNA binding and cleavage activities have been characterized (22) . The presumed infrequency of recognition sites in even very complex genomes makes I-Sce I an ideal endonuclease to study the repair of DSBs at defined sites.
With this goal in mind, we have constructed an I-Sce I expression vector for use in mammalian cells. We have begun to examine the effects of in vivo-generated DSBs on homologous recombination by using an extrachromosomal assay that measures reporter gene activity. We also address the question as to whether expression of I-Sce I has any deleterious consequences for murine cells.
MATERIAL AND METHODS DNA Constrc. All I-Sce I plasmids were prepared in Escherichia coli JM101. The universal code equivalent of I-Sce 1 (23) was derived from pSCM525 (B. Dujon, Pasteur Institute). The 714-bp Nde I/Sal I fiagment from pSCM525 was cloned into the Nde I and Sal I sites ofpUC19, generating pUC19/I-Sce I. The unique Nde I site overlaps the ATG for I-Sce I. The influenza hemagglutinin (HA) epitope tag (24) was inserted by using the oligonucleotides 5'-TATGTAC-CCATACGATGTTCCTGACTATGCGGG and 5'-TAC-CCGCATAGTCAGGAACATCGTATGGGTACA. Annealing these generates a double-stranded oligonucleotide with Nde I overhangs, which was ligated into the Nde I site of pUC19/I-Sce I. In the correct orientation, the Nde I site is reconstructed on the 5' side of the HA-I-Sce I fusion, generating pUC19/HA-I-Sce I. A nuclear localization signal (25) was inserted in a similar manner in the Nde I site of pUC19/HA-I-Sce I, generating pUC19/nls-HA-I-Sce I, with the oligonucleotides 5'-TATGGGATCATCATCAGAC-GACGAAGCAACAGCAGACGCACAACACGCAGCAC-CACCAAAAAAAAAACGAAAAGTAGAAGACCCAC-GATT and 5'-TAAATCGTGGGTCTTCTACTTT-TCGTTT TTTTT TTGGTGGTGCTGCGTGTTGTG-CGTCTGCTGTTGCTTCGTCGTCTGATGATGATCCCA. A consensus eukaryotic translation initiation site (26) 
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Sal I fragment of pUC19/Kozak-nls-HA-I-Sce I into the Bgl II/Sal I sites of plasmid pCMV5 (27) .
All recombination substrates were prepared in E. coli XL1-Blue. Plasmid 4 has been described previously (28) . Plasmids 5 and 6 were obtained by addition of a synthetic I-Sce I site (20) into the unique Xba I site of plasmid 4, which is situated between the chloramphenicol acetyltransferase (CAT) gene repeats. The synthetic site was obtained by annealing the oligonucleotides 5'-CTAGATAGGGATAA/ CAGGGTAATA and 5'-CTAGTATTACCCTG/TTATC-CCTAT. (The site of I-Sce I cleavage is indicated by the slash.) The CAT repeats are separated by 17 bp in plasmid 4 and 39 bp in plasmids 5 and 6. Plasmids 5 and 6 have the I-Sce I site in opposite orientations, as distinguished by the reconstruction of the Xba I site on opposite sides of the I-Sce I site. The integrity of the site in these plasmids was verified by in vitro cleavage with purified I-Sce I (Meganuclease; Boehringer Mannheim). Plasmids A5' and A3' were constructed by deletion ofthe Mlu I/Xba I 5' CAT fragment ofplasmid 5 and the 3' CAT Xba I/Hpa I fragment of plasmid 6, respectively, using Klenow fill-in of the DNA ends followed by blunt-end ligation. Plasmids AS' and A3' each contain an I-Sce I site at the 5' and 3' ends, respectively, of the one remaining CAT repeat.
Cell Culture, Enzyme Assays, and Southern Analysis. COS1
and 3T3 cells were cultured on 10-cm-diameter plates and transfected by the calcium phosphate protocol as described (29) without reducing the percentage of CO2 in the incubator. For COS1 cell transfections, which were performed in triplicate, 35 pg of DNA was used: 15 ,g of the CAT plasmid(s), 15 pg of pCMV-I-Sce I (or pCMV5, as a control), and 5 ug of plasmid pgkH21acZ (P.R., unpublished results), which was used to monitor transfection efficiency. Cells were harvested 60 h after transfection. CAT and (3-galactosidase assays were performed as described (30) 
RESULTS

Design of a Vector for Expression of I-Sce I in Mamli
Cells. Since I-Sce I is encoded by the yeast mitochondrial genome, its genetic code differs from the universal code. However, a universal code equivalent has previously been constructed for expression of the protein in E. coli (23) . To direct expression of I-Sce I in mammalian cells, a DNA fragment containing the universal code equivalent for I-Sce I was subcloned into a mammalian expression vector. Initial attempts to detect endonucleolytic cleavage in vivo proved unsuccessful with this construct. Therefore, three modifications were undertaken (Fig. 1) . Oligonucleotides encoding a simian virus 40 (SV40) nuclear localization signal (nls) and an HA epitope tag were fused in-frame to the 5' end of the I-Sce I coding region. A consensus eukaryotic translation initiation site (26) was also added. The modified I-Sce I gene was inserted into the pCMVS expression vector (27) , which has the strong human cytomegalovirus promoter/enhancer, a human growth hormone polyadenylylation site, and an SV40 origin for replication of the plasmid in COS1 cells. The complete vector is called pCMV-I-Sce I.
Expression of I-Sce I in COS1 cells transiently transfected with pCMV-I-Sce I was monitored by Northern blot analysis. A 1-kb I-Sce I-specific RNA accumulated rapidly, reaching very high levels 60 h posttransfection (data not shown). Although we have not as yet detected the protein via the epitope tag, functional studies have demonstrated the expression of the protein (see below).
Design of Recombination Substrates. In a wide variety of mammalian cells, extrachromosomal homologous recombination is stimulated when the transfected DNA has a DSB at the homology region. To detect enhanced recombination through the introduction of DSBs by I-Sce I in vivo, we have utilized plasmid substrates that are unable to express CAT except by a homologous recombination event (28) . CAT plasmid substrates are designed to measure both intramolecular and intermolecular recombination in transient transfections of mammalian cells (Fig. 2) .
Plasmids 4 and 5 are intramolecular substrates in which the CAT coding region contains an internal 403-bp duplication, rendering the gene nonfunctional. Homologous recombination within the repeats leads to a functional CAT gene expressed from the Rous sarcoma virus (RSV) promoter. In both plasmids, anXba I site is present between the duplicated sequences. Plasmid 5 also has an I-Sce I site between the repeats. The intermolecular substrates, plasmids A5' and A3', have deletions at either the 5' or 3' ends of the CAT gene, respectively, which are delimited by an I-Sce I site. Recombination between plasmids AS' and A3' also leads to a functional CAT gene. None of the substrates contain a mammalian replication origin.
I-Scc I Is Active in Mammian Cells and Stimutes Extrac r_ Recombination. To monitor extrachromosomal recombination, plasmid substrates were transfected into COS1 cells, and CAT assays were performed 60 h posttransfection. In control transfections with uncut plasmids 4 and 5, we detected a low level of CAT activity that was similar for both plasmids (data not shown). As expected from our previous work (28), the amount of activity increased 10-fold if the DNA was cleaved between the repeats prior to transfection. The activity from the cleaved substrates was -lO% that of the wild-type RSVCAT gene, indicating that 109o of the cut plasmid DNA recombined (data not shown).
To assess whether the I-Sce I endonuclease was functional in vivo and whether in vivo DSBs would enhance extrachromosomal recombination, plasmid substrates were cotransfected with pCMV-I-Sce I (Fig. 3A) . Plasmid 5, which contains the I-Sce I site, produced a 3-to 4-fold higher level of CAT activity than did plasmid 4, which has no I-Sce I site.
The level of activity is z40%o that obtained if the plasmid DNA was cleaved between the repeats prior to transfection.
Our interpretation is that a significant amount of plasmid 5 is strates. An I-Sce I site is present in plasmids 2.0 5, A5', and A3', but is absent from plasmid 4.
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The CAT sequences are shaded; the repeated sequence has a lighter shading. Expression of I-Sce I also enhanced intermolecular recombination (Fig. 3B) . The substrates A5' and A3' by themselves showed very low CAT activity. When A5' and A3' were transfected together with pCMV5, a somewhat higher level of activity was observed, indicating a small amount of intermolecular recombination. This was increased almost 10-fold by I-Sce I expression, reaching almost 40% the level of activity obtained with the pre-cleaved substrates. This suggests that both A5' and A3' were efficiently cleaved in vivo by I-Sce I, stimulating recombination.
To monitor I-Sce I endonuclease cleavage in vivo and to verify that the enhanced CAT activity was due to recombination, the CAT plasmids were isolated from COS1 cells, cleaved with HindIII, and analyzed by Southern blotting. Fig. 4 shows results from transfections with the intermolecular substrates. These transfections were performed in parallel to those used for the CAT assays shown in Fig. 3B . When the substrates were cleaved with I-Sce I prior to transfection, bands of 2 kb and 0.6 kb were detected, from the combined I-Sce I/HindIII digestion of A5' and A3', respectively (lane 1). When they were transfected uncut, they showed the HindIII cleavage products of 4.9 kb and 1.3 kb, respectively (lane 3). Cotransfection of pCMV-I-Sce I with the uncut substrates produced both the HindIII and the I-Sce I/HindIII cleavage products, verifying that I-Sce I was functional in vivo. Uncut A3' showed the HindIII band of 1.3 kb and the I-Sce I/HindIII band of 0.6 kb (lane 4), whereas AS' showed the HindIII band of 4.9 kb and the I-Sce I/HindIII band of 2 kb (lane 5). When A3' and A5' were cotransfected along with pCMV-I-Sce I, all four bands were observed (lane 2). In this experiment, more than half of plasmid A5' was cleaved by I-Sce I. Somewhat less A3' was cleaved, although it is more difficult to quantitate the smaller cleavage product. A substantial level of in vivo cleavage was also detected with the intramolecular substrate (data not shown).
In addition to the cleavage products, the recombination product of 2.2 kb was also detected by Southern analysis (Fig. 4) . This band was seen ifthe substrates A5' and A3' were cleaved in vitro by I-Sce I prior to transfection (lane 1) or if they were cleaved in vivo by expressed I-Sce I (lane 2). The recombined product was not detected if they were transfected uncut with the control pCMV5 vector (lane 3).
A similar amount of the recombined product was apparent in two experiments for both the in vitro-cleaved and the in vivo-cleaved DNA. Considering that the in vivo-cleaved DNA produced less CAT activity, -60% less recombined DNA might have been expected with in vivo cleavage. pCMV-I-Sce I, recombination will be stimulated later in the transfection, as I-Sce I accumulates, than if the substrates were introduced cleaved. In that case, the CAT activity would experience a lag.
In addition to HindIII, Southern analysis of the isolated DNA was performed using a second restriction endonuclease digestion (Kpn I/Sca I; data not shown). Similar results were obtained that further substantiated in vivo cleavage by I-Sce I and the appearance of the recombined product.
Constitutive Exnpeon of I-Sce I Is not Toxic to Murine
Cells. Constitutive expression of I-Sce I could potentially be toxic to cells through the introduction of lesions in genomic DNA. Such deleterious effects may not be readily apparent in transient transfections. To determine if constitutive expression of I-Sce I is toxic to murine cells, stable transformations were performed. The expression plasmid pCMV-ISce I was transfected into 3T3 cells along with a selectable neo gene, under conditions that result in a high cotransfection efficiency, and G418-resistant colonies were selected. No difference in the number of G418-resistant colonies was evident in the cotransfections with pCMV-I-Sce I versus those without it. Northern blot analysis was performed on six randomly isolated clones, and five of these showed significant levels of I-Sce I mRNA (data not shown).
To verify that I-Sce I is produced in these cell lines and that it is functional, cells were electroporated with uncut A5' and A3' to monitor cleavage at their I-Sce I sites. DNA was isolated immediately after electroporation and at time points up to 8 h later. Southern blot analysis on HindIII-cleaved DNA is shown in Fig. 5 . For the parental 3T3 cells, the DNA appeared unchanged 8 h after electroporation. However, the pCMV-I-Sce 1-transfected clone 7E had a significant fraction of the plasmids cleaved at their I-Sce I sites, as first detected 4 h after transfection. For AS', the 4.9-kb plasmid was cut to produce a 2.0-kb band, and for A3', the 1.3-kb HindIll band was cut to produce 0.6-and 0.7-kb I-Sce I/HindIm bands. Clearly, I-Sce I is constitutively produced in this cell line, and it can efficiently cleave introduced DNA. In addition to the cleavage products, the recombined product of A5' and A3' was also seen.
To quantitate the level of recombination in the cell lines producing I-Sce I, CAT activity was measured after transient transfections of both the intramolecular and intermolecular genome. However, base pair substitutions within the recognition site are tolerated by the purified enzyme, although they reduce the cleavage efficiency by various degrees (20) . Expression of site-specific endonucleases in mammalian cells will provide a powerful tool in genome studies. One application would be the creation of nested sets of chromosome deletions, in a modification of the telomere-associated chromosome fiagmentation-approach (36, 37) . In addition, the introduction of I-Sce I recognition sites into the genome, either randomly or by gene targeting, will allow a more precise analysis of the repair of chromosomal DSBs than has so far been possible. As 
